Recently, prompted by the success of two specialized firms, several newer companies have begun to invest in the research of academic institutions, funding R&D and start-ups. The two companies, IP Group and Imperial Innovations, each owns shares worth hundreds of millions of dollars in close to 100 companies. To realize the promise of university technologies, […]
This month, the US FDA approved for the first time a virus engineered to fight cancer. A therapy for advanced melanoma, the genetically engineered virus, talimogene laherparepvec (T-VEC) is a herpesvirus that triggers an immune response against cancer. Cancer cells often cannot mount normal antiviral responses, resulting in their preferential infection by viruses. The infected […]
In this article, IBO presents the second report in its biannual review of new patent infringements suits involving analytical instrument and lab product companies. New Cases In May, the University of Pittsburgh filed suit in the US District for the Western District of Pennsylvania against PerkinElmer, alleging infringement of five patents (see table below), which […]
The US equity markets rebounded sharply in October as the Dow Jones Industrial Average, S&P 500 and NASDAQ climbed 8.5%, 8.3% and 9.4%, respectively. Stronger-than-expected corporate earnings, especially from telecom, health care and consumer staples sectors, boosted equity prices, along with unchanged interest rates and historically low jobless claims. Third quarter GDP came in just […]
St. Louis, MO 10/29/15—Sigma-Aldrich has agreed to acquire the Duolink product portfolio from Olink Bioscience for an undisclosed amount. Duolink allows visualization of low levels of proteins, protein modifications and protein interactions in fixed cells and tissue samples. The acquired assets include intellectual property, sales, marketing and manufacturing assets. Sigma has distributed the product line […]
Mannedorf, Switzerland 10/28/15—Lab instrument company Tecan has agreed to acquire Swiss firm SIAS, an OEM supplier of lab automation solutions with 80 employees. The transaction is valued at one times SIAS’s expected fiscal 2015 sales of CHF 25 million ($26 million = CHF 0.98 = $1). SIAS will join Tecan’s Partnering Business. “SIAS will add […]
Irvine, CA 10/26/15—The Orange County Business Journal reported that MP Biomedicals has been sold to Chinese chemical firm Valiant, a supplier of liquid crystal materials, pharmaceutical intermediates and photoelectronic chemicals, for around $134 million. MP Biomedicals is a provider of life science and diagnostic lab products, including life science consumables and lab chemicals. MP Chemicals […]
This month, the Organization for Economic Co-operation and Development (OECD) released its annual Science, Technology and Industry Scoreboard, highlighting trends in R&D spending among the 34 countries that make up the OECD as well as China. In particular, the report emphasized the recent trends of growing investment by business, China’s increasing R&D prominence and the […]
Despite indications that the global economy is continuing to slow, the outlook for sales growth within the instrument and lab product industry is positive. In late October, 15 industry executives completed the online IBO Business Climate Survey. The respondents were IBO subscribers and other solicited participants, each representing a unique company or business unit. The […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
